This is a Validated Antibody Database (VAD) review about mouse Tigit, based on 15 published articles (read how Labome selects the articles), using Tigit antibody in all methods. It is aimed to help Labome visitors find the most suited Tigit antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Tigit synonym: Vstm3

BioLegend
mouse monoclonal (1G9)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Tigit antibody (BioLegend, 142104) was used in flow cytometry on mouse samples (fig 2a). Sci Adv (2022) ncbi
mouse monoclonal (1G9)
  • flow cytometry; mouse; 1:700; loading ...; fig s2e
BioLegend Tigit antibody (BioLegend, 1G9) was used in flow cytometry on mouse samples at 1:700 (fig s2e). Sci Adv (2021) ncbi
mouse monoclonal (1G9)
  • flow cytometry; mouse; 1:100; loading ...; fig s1b
BioLegend Tigit antibody (Biolegend, 142106) was used in flow cytometry on mouse samples at 1:100 (fig s1b). Nat Commun (2021) ncbi
mouse monoclonal (1G9)
  • flow cytometry; mouse
BioLegend Tigit antibody (Biolegend, 142102) was used in flow cytometry on mouse samples . Cancer Cell (2021) ncbi
mouse monoclonal (1G9)
  • flow cytometry; mouse; 1:100; loading ...; fig s22a
BioLegend Tigit antibody (Biolegend, 1G9) was used in flow cytometry on mouse samples at 1:100 (fig s22a). Nat Commun (2021) ncbi
mouse monoclonal (1G9)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend Tigit antibody (Biolegend, 1G9) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2021) ncbi
mouse monoclonal (1G9)
  • flow cytometry; mouse; 1:100; fig 2e
BioLegend Tigit antibody (BioLegend, 1G9) was used in flow cytometry on mouse samples at 1:100 (fig 2e). Nat Commun (2021) ncbi
mouse monoclonal (1G9)
  • flow cytometry; mouse; 1:100; loading ...; fig s2h
BioLegend Tigit antibody (BioLegend, 1G9) was used in flow cytometry on mouse samples at 1:100 (fig s2h). Nat Immunol (2021) ncbi
mouse monoclonal (1G9)
  • flow cytometry; mouse; loading ...
BioLegend Tigit antibody (BioLegend, clone 1G9) was used in flow cytometry on mouse samples . elife (2020) ncbi
mouse monoclonal (1G9)
  • flow cytometry; mouse; fig 4
BioLegend Tigit antibody (BioLegend, 1G9) was used in flow cytometry on mouse samples (fig 4). PLoS Pathog (2016) ncbi
mouse monoclonal (1G9)
  • flow cytometry; mouse; 1:200
BioLegend Tigit antibody (Biolegend, 1G9) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2014) ncbi
Invitrogen
rat monoclonal (GIGD7)
  • flow cytometry; mouse; fig 1
In order to investigate how organ-specific Btnl genes shape local T cell compartments, Invitrogen Tigit antibody (eBiosciences, 12-9501-82) was used in flow cytometry on mouse samples (fig 1). Cell (2016) ncbi
rat monoclonal (GIGD7)
  • flow cytometry; mouse; loading ...; fig 5
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, Invitrogen Tigit antibody (eBioscience, GIGD7) was used in flow cytometry on mouse samples (fig 5). J Clin Invest (2016) ncbi
rat monoclonal (GIGD7)
  • flow cytometry; mouse; loading ...; fig 2b
In order to investigate the role of TIGIT in the immune response, Invitrogen Tigit antibody (eBioscience, GIGD7) was used in flow cytometry on mouse samples (fig 2b). J Clin Invest (2015) ncbi
rat monoclonal (GIGD7)
  • flow cytometry; mouse; fig 3
Invitrogen Tigit antibody (eBioscience, GIGD7) was used in flow cytometry on mouse samples (fig 3). Nat Immunol (2015) ncbi
Articles Reviewed
  1. Que W, Ma K, Hu X, Guo W, Li X. Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells. Sci Adv. 2022;8:eabo4413 pubmed publisher
  2. Rizvi Z, Dalal R, Sadhu S, Kumar Y, Kumar S, Gupta S, et al. High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity. Sci Adv. 2021;7:eabg5016 pubmed publisher
  3. Petley E, Koay H, Henderson M, Sek K, Todd K, Keam S, et al. MAIT cells regulate NK cell-mediated tumor immunity. Nat Commun. 2021;12:4746 pubmed publisher
  4. Hutton C, Heider F, Blanco Gómez A, Banyard A, Kononov A, Zhang X, et al. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity. Cancer Cell. 2021;: pubmed publisher
  5. Ho D, Tsui Y, Chan L, Sze K, Zhang X, Cheu J, et al. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma. Nat Commun. 2021;12:3684 pubmed publisher
  6. Amoozgar Z, Kloepper J, Ren J, Tay R, Kazer S, Kiner E, et al. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Nat Commun. 2021;12:2582 pubmed publisher
  7. Page N, Lemeille S, Vincenti I, Klimek B, Mariotte A, Wagner I, et al. Persistence of self-reactive CD8+ T cells in the CNS requires TOX-dependent chromatin remodeling. Nat Commun. 2021;12:1009 pubmed publisher
  8. Yao C, Lou G, Sun H, Zhu Z, Sun Y, Chen Z, et al. BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells. Nat Immunol. 2021;22:370-380 pubmed publisher
  9. Gryzik S, Hoang Y, Lischke T, Mohr E, Venzke M, Kadner I, et al. Identification of a super-functional Tfh-like subpopulation in murine lupus by pattern perception. elife. 2020;9: pubmed publisher
  10. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed publisher
  11. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  12. Yasuma K, Yasunaga J, Takemoto K, Sugata K, Mitobe Y, Takenouchi N, et al. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT). PLoS Pathog. 2016;12:e1005372 pubmed publisher
  13. Kurtulus S, Sakuishi K, Ngiow S, Joller N, Tan D, Teng M, et al. TIGIT predominantly regulates the immune response via regulatory T cells. J Clin Invest. 2015;125:4053-62 pubmed publisher
  14. Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Pérals C, et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 2015;16:628-34 pubmed publisher
  15. Burton B, Britton G, Fang H, Verhagen J, Smithers B, Sabatos Peyton C, et al. Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nat Commun. 2014;5:4741 pubmed publisher